Búsqueda de LIBROS DEL AUTOR: harry yang

5 resultados

  • DATA SCIENCE, AI, AND MACHINE LEARNING IN DRUG DEVELOPMENT
    HARRY YANG
    The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven ...

    $1,339.00

  • REAL-WORLD EVIDENCE IN DRUG DEVELOPMENT AND EVALUATION
    HARRY YANG
    Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book syst...

    $1,239.00

  • BAYESIAN ANALYSIS WITH R FOR DRUG DEVELOPMENT
    HARRY YANG / STEVEN NOVICK
    Drug development is an iterative process. The recent publications of regulatory guidelines further entail a lifecycle approach. Blending data from disparate sources, the Bayesian approach provides a flexible framework for drug development. Despite its advantages, the uptake of Bayesian methodologies is lagging behind in the field of pharmaceutical development. Written specifica...

    $1,099.00

  • EMERGING NON-CLINICAL BIOSTATISTICS IN BIOPHARMACEUTICAL DEVELOPMENT AND MANUFACTURING
    HARRY YANG
    The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-d...

    $1,239.00

  • STATISTICAL METHODS FOR IMMUNOGENICITY ASSESSMENT
    HARRY YANG / JIANCHUN ZHANG / BINBING YU / WEI ZHAO
    Develop Effective Immunogenicity Risk Mitigation StrategiesImmunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation. Using advanced statistical methods in the study design and analysis stages is therefore essential to immunogenicity risk assessment and mitigation stra ...

    $1,239.00